Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
29.00
-0.54 (-1.83%)
At close: Aug 24, 2026

SHA:688139 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
997.82843.83901.231,269951.78774.39
Trading Asset Securities
553.59447.59877.25651.142,0242,130
Cash & Short-Term Investments
1,5511,2911,7781,9202,9752,904
Cash Growth
7.26%-27.39%-7.39%-35.46%2.45%28.69%
Accounts Receivable
488.1445.28352.76208.35192.17136.29
Other Receivables
13.088.058.567.473.9932
Receivables
501.18453.33361.32215.82196.16168.29
Inventory
333.94345.47334.74248.02270.55345.75
Prepaid Expenses
--0.142.561.210.41
Other Current Assets
419.18568.62177.77149.2145.1938.23
Total Current Assets
2,8062,6592,6522,5363,4893,457
Property, Plant & Equipment
938.94923.01915.18862.22802.08464.13
Long-Term Investments
241.75981.39972.711,030371.85358.34
Goodwill
757.72758.24757.87642.68451.3323.45
Other Intangible Assets
338.6360.5402.3367.73312.35241.62
Long-Term Deferred Tax Assets
100.0789.6766.0151.6730.5235.43
Long-Term Deferred Charges
5.485.66.725.695.460.5
Other Long-Term Assets
638.4414.2514.2429.1826.9119.53
Total Assets
5,8275,7925,7875,5265,4894,900

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
485.55429.38427.6390.98485.06431.57
Accrued Expenses
101.98242.19228.65235.15245.6196.05
Short-Term Debt
10.0110.0110.016.0110.01-
Current Portion of Long-Term Debt
-10----
Current Portion of Leases
-5.015.763.425.481.65
Current Income Taxes Payable
-23.6635.2135.828.6848.01
Current Unearned Revenue
105170.92151.98111.81232.84362.05
Other Current Liabilities
352.21194.33163.2158.51176.81104.17
Total Current Liabilities
1,0551,0851,022941.661,1841,144
Long-Term Leases
2.944.547.438.6910.674.32
Long-Term Unearned Revenue
50.3426.0823.1728.6232.8832.18
Long-Term Deferred Tax Liabilities
42.7645.8952.5146.9943.5925.9
Other Long-Term Liabilities
6.546.3163.8159.7569.0355.18
Total Liabilities
1,1571,1681,1691,0861,3411,261

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
316.49317.95317.95317.95317.95317.07
Additional Paid-In Capital
1,8851,9761,9771,9871,9951,913
Retained Earnings
2,3672,3232,2192,0151,7511,309
Treasury Stock
-149.71-248.68-140.2-99.74-98.07-
Comprehensive Income & Other
2.997.46-2.6910.3753.8984.34
Total Common Equity
4,4214,3764,3724,2314,0213,623
Minority Interest
247.96247.5246.59209.25127.7115.95
Shareholders' Equity
4,6694,6234,6184,4404,1483,639
Total Liabilities & Equity
5,8275,7925,7875,5265,4894,900

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
12.9429.5523.218.1126.155.97
Net Cash (Debt)
1,5381,2621,7551,9022,9492,898
Net Cash Growth
8.68%-28.11%-7.73%-35.50%1.76%29.86%
Net Cash Per Share
4.944.035.556.009.289.12
Filing Date Shares Outstanding
309.45311.71314.48315.68316.49317.07
Total Common Shares Outstanding
309.45311.75314.48316.47316.49317.07
Working Capital
1,7511,5731,6301,5942,3042,313
Book Value Per Share
14.2914.0413.9013.3712.7011.43
Tangible Book Value
3,3253,2573,2113,2203,2573,058
Tangible Book Value Per Share
10.7510.4510.2110.1810.299.64
Buildings
-785.74696.63649.88257.73243.72
Machinery
-359.68333.52284.75240.79151.04
Construction In Progress
-54.9795.0370.33389.34130.96